Control of drooling with transdermal scopolamine in a child with cerebral palsy.
Transdermal scopolamine patches (1.5 mg) were used to control drooling in a two-year-old boy with severe spastic quadriparetic cerebral palsy and developmental delay. He responded well to the continuous scopolamine therapy, with a decrease in drooling, and a secondary decrease in respiratory distress and frequency of suctioning. No significant side-effects were noted.
Siegel
L K
LK
Medical College of Wisconsin.
Klingbeil
M A
MA
D000279:Administration, Cutaneous; D002547:Cerebral Palsy / Q000188:drug therapy*; D002675:Child, Preschool; D006801:Humans; D008134:Long-Term Care; D008297:Male; D012472:Salivation / Q000187:drug effects; D012601:Scopolamine / Q000008:administration & dosage*; D012798:Sialorrhea / Q000188:drug therapy*
D012601:Scopolamine